Insight — discharge medicines reconciliation — get this right and you prevent harm.

A working discharge reconciliation programme should be measured on three things: volume processed against SLA, number of clinically significant issues identified, and avoided harm where the chain of evidence supports it. PCNs running structured reconciliation typically identify a clinically significant issue in 15 to 30 per cent of discharge summaries — issues that, without reconciliation, would have either reached the patient or generated a downstream safety event. That evidence base is one of the cleanest IIF medication safety stories a PCN can produce.

Discharge medicines reconciliation deserves more board-level attention in PCNs than it usually gets. Every clinically significant intervention identified by a reconciliation pharmacist is, definitionally, an avoided harm — a wrong dose corrected, a stopped medicine restarted, a missing monitoring booking caught. Across a year of structured reconciliation a PCN of typical size will identify hundreds of these interventions, each one a concrete patient safety event that did not happen. That is the patient safety story Clinical Directors should be telling at PCN board meetings, at ICB integration meetings, and in CQC conversations.

It is also the workstream that most directly links primary care pharmacist input to acute trust activity, which makes it one of the strongest places to start system-level conversations about pharmacist deployment. Trusts care about avoidable readmission. Primary care reconciliation reduces it. The two systems sharing reconciliation outcomes data — even informally — produces a faster, safer transition of care for the patients both sides serve.